US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist

20.930
+0.290+1.41%

Trading Oct 15 10:20 ET

2.48BMarket Cap37.38P/E (TTM)

Catalyst Pharmaceuticals Stock Forum

Tonyco

Yesterday 08:16

$KinderCare Learning Companies (KLC.US)$
$Catalyst Pharmaceuticals (CPRX.US)$
eyooooooo

Stock_Drift

Sep 24 05:04

$Catalyst Pharmaceuticals (CPRX.US)$

Bigmoney Dreamer

Aug 29 08:04

$Catalyst Pharmaceuticals (CPRX.US)$ P/L= +0.5% in 8 days

Bigmoney Dreamer

Aug 21 13:31

$Catalyst Pharmaceuticals (CPRX.US)$

Trytosaveabit

Jul 24 07:12

Update

$Catalyst Pharmaceuticals (CPRX.US)$ Catalyst Pharmaceuticals Enters Exclusive License, Supply And Commercialization Agreement Granting Kye Pharmaceuticals Canadian Rights To AGAMREE For Duchenne Muscular Dystrophy

Meltyy

May 24 03:20

See remaining FDA PDUFAs in May 👀👇
$Bristol-Myers Squibb (BMY.US)$ : Breyanzi
‣ PDUFA date: 5/31/24 (sBLA)
$Moderna (MRNA.US)$ : mRNA-1345
‣ PDUFA date: End of May 2024 (est.) (BLA)
📣 Buckle up & get ready for next month...
June brings 17 PDUFA decisions: 🔥 🔥
$Catalyst Pharmaceuticals (CPRX.US)$ : FIRDAPSE® (Amifampridine)
$GlaxoSmithKline (GSK.US)$ : Arexvy
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : Elafibranor
$Regeneron Pharmaceuticals (REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb (BMY.US)$ : Augtyro...

Trytosaveabit

May 8 15:21

Solid

$Catalyst Pharmaceuticals (CPRX.US)$ May 08 (Reuters) - Catalyst Pharmaceuticals Q1 Net Income USD 23.3 Million.
Q1 Adjusted Net Income USD 46.8 Million Vs. Ibes Estimate USD 23.7 Million
Q1 Operating Income USD 27.1 Million Vs. Ibes Estimate USD 25.1 Million
Outlook FY Revenue USD 455-475 Million

Moomoo AI

Mar 22 09:45

The absence of insider buying at Catalyst Pharmaceuticals over the past year is concerning. However, the high level of insider ownership indicates alignment with shareholder interests. Insider selling, even below the current price, raises questions about their view on the company's valuation.

Possible Bearish Signals With Catalyst Pharmaceuticals Insiders Disposing Stock

MARKET-TEST-DUMMY

Jan 28 18:24

hello?

$Catalyst Pharmaceuticals (CPRX.US)$ are you looking at me?

Moomoo AI

Jan 4 11:22

Investors are ostensibly keeping Catalyst Pharmaceuticals' P/E high due to expectations of its future growth surpassing the market. Currently, shareholders are confident in future earnings and do not foresee a significant dip in the share price in the near future.

Why Investors Shouldn't Be Surprised By Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) P/E

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data